These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1987991)

  • 41. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
    Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL)-apheresis.
    Mabuchi H; Fujita H; Michishita I; Takeda M; Kajinami K; Koizumi J; Takeda R; Takegoshi T; Wakasugi T; Ueda K
    Atherosclerosis; 1988 Aug; 72(2-3):183-8. PubMed ID: 3145745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.
    Marais AD; Firth JC; Bateman ME; Byrnes P; Martens C; Mountney J
    Arterioscler Thromb Vasc Biol; 1997 Aug; 17(8):1527-31. PubMed ID: 9301631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
    Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study.
    Yoshida H; Ishikawa T; Ayaori M; Shige H; Hosoai H; Nishio E; Tomiyasu K; Yamashita T; Suzukawa M; Nishiwaki M
    Clin Ther; 1995; 17(3):379-89. PubMed ID: 7585842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Stohler R; Keller U; Riesen WF
    Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
    Dart A; Jerums G; Nicholson G; d'Emden M; Hamilton-Craig I; Tallis G; Best J; West M; Sullivan D; Bracs P; Black D
    Am J Cardiol; 1997 Jul; 80(1):39-44. PubMed ID: 9205017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
    Bach LA; Cooper ME; O'Brien RC; Jerums G
    J Am Geriatr Soc; 1990 Jan; 38(1):10-4. PubMed ID: 2404052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term therapy with high-dose simvastatin does not affect adrenocortical and gonadal hormones in hypercholesterolemic patients.
    Azzarito C; Boiardi L; Zini M; Agosti A; Dotti C; Biagi R; Portioli I
    Metabolism; 1992 Feb; 41(2):148-53. PubMed ID: 1310516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.
    De Knijff P; Stalenhoef AF; Mol MJ; Gevers Leuven JA; Smit J; Erkelens DW; Schouten J; Frants RR; Havekes LM
    Atherosclerosis; 1990 Jul; 83(1):89-97. PubMed ID: 2390138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
    Hagemenas FC; Illingworth DR
    Arteriosclerosis; 1989; 9(3):355-61. PubMed ID: 2719596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia.
    Smith DH; Neutel JM; Jankelow D; Myburgh DP
    S Afr Med J; 1990 May; 77(10):500-3. PubMed ID: 2188379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia.
    Johansson J; Mölgaard J; Olsson AG
    Atherosclerosis; 1991 Dec; 91(3):175-84. PubMed ID: 1789802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia.
    Hagemenas FC; Pappu AS; Illingworth DR
    Eur J Clin Invest; 1990 Apr; 20(2):150-7. PubMed ID: 2112479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
    Rabelink AJ; Hené RJ; Erkelens DW; Joles JA; Koomans HA
    Lancet; 1988 Dec; 2(8624):1335-8. PubMed ID: 2904053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.
    Cabezas MC; de Bruin TW; Kock LA; Kortlandt W; Van Linde-Sibenius Trip M; Jansen H; Erkelens DW
    Metabolism; 1993 Apr; 42(4):497-503. PubMed ID: 8487674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
    Simons LA
    Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Simvastatin in the treatment of familial hypercholesterolemia].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.